Kallikrein 5 inhibitors (GSK/INSERM)

N/A

Report date: 2025/03/20 15:40:22
NME

Base Information

Drug NameKallikrein 5 inhibitors (GSK/INSERM)
Drug Alias NameKallikrein 5 inhibitors (GlaxoSmithKline/INSERM)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKallikrein-5 inhibitors
TargetsKallikrein-5
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A